Caleb Ekuban
31-Year-Old
Genoa
Serie A
OUT
Injury Thigh
Est. Return 9/15/2025
Nursing muscular problem
Ekuban is poised to be unavailable versus Lecce in two weeks due to a flexor strain, Il Secolo XIX relayed.
ANALYSIS
Ekuban sustained the problem about a week ago and is believed to have an outside shot to be ready for the second tilt of the season versus Juventus. Vitinha, Lorenzo Colombo and Jeff Ekhator will absorb his minutes.
Ekuban sustained the problem about a week ago and is believed to have an outside shot to be ready for the second tilt of the season versus Juventus. Vitinha, Lorenzo Colombo and Jeff Ekhator will absorb his minutes.
Soccer Season Stats
Season Stats
Per 90
Per Game
Soccer Season Stats
Loading Per Game Stats...
2025 Soccer Game Log
Current Season
Previous Season
2025 Soccer Game Log
Loading Game Log...
Set Pieces / Depth Chart
More Fantasy News
Deployed late versus Atalanta
Ekuban (thigh) had one key pass and committed two fouls in 13 minutes in Saturday's 3-2 loss to Atalanta.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Fit for bench
Ekuban (thigh) is on the bench for Saturday's match against Atalanta.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Returning against Atalanta
Ekuban (undisclosed) "will be part of the squad Saturday," coach Patrick Vieira announced.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Absent against Como
Ekuban (undisclosed) won't recover for Sunday's meeting with Como, coach Patrick Vieira stated.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Will sit out Lazio tilt
Ekuban (undisclosed) hasn't been called up for Wednesday's game versus Lazio, Genoa announced.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.